Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

VCEL Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: June 05, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Vericel Corp (VCEL)

Based on 14 analysts giving stock ratings to Vericel Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
36
Buy
50
Hold
14
Sell
0
Strong Sell
0
Vericel Corp

Vericel Corp. Stock Analysis VCEL

United States Health Care Small Cap Report:
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. The company is headquartered in Cambridge, Massachusetts and currently employs 398 full-time employees. The company has a differentiated portfolio of cell therapy and specialty biologic products. The company markets three products in the United States. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous-cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. The firm also holds a license for North American rights to NexoBrid (anacaulase-bcdb), a biological orphan product containing proteolytic enzymes, which is indicated for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns.
Read More

Vericel Corp (VCEL) Chart

Key Statistics of Vericel Corp (VCEL)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$39.98$41.02

Today's Open

$40.50

Volume

430.14K

P/E Ratio (TTM)

123.98

52 Week Range

$28.95$43.57

Market Cap

1.76B

Avg. Volume

629.78K

Dividend Yield

-

Financial Metrics & Statements of Vericel Corp (VCEL)

FAQ's for Vericel Corp (VCEL)

  • According to Musaffa’s Shariah screening methodology, Vericel Corp (VCEL) is currently classified as HALAL as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Vericel Corp using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Vericel Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Vericel Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Vericel Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Vericel Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.